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Background: To assess whether the techniques of percutaneous needle electrolysis (PNE) and deep dry needling 
(DDN) used on trigger points (TrP) of lateral pterygoid muscle (LPM) can significantly reduce pain and improve 
function in patients with myofascial pain syndrome (MPS) compared to a control group treated with a sham nee-
dling procedure (SNP). 
Material and Methods: Sixty patients diagnosed with MPS in the LPM were selected and randomly assigned to 
one of three groups. The PNE group received electrolysis to the LPM via transcutaneous puncture. The DDN 
group received a deep puncture to the TrP without the introduction of any substance. In the SNP group, pressure 
was applied to the skin without penetration. Procedures were performed once per week for 3 consecutive weeks. 
Clinical evaluation was performed before treatment, and on days 28, 42 and 70 after treatment.
Results: Statistically significant differences (p <0.01) were measured for the PNE and DDN groups with respect to 
pain reduction at rest, during chewing, and for maximum interincisal opening (MIO). Values for the PNE group 
showed significantly earlier improvement. Differences for PNE and DDN groups with respect to SNP group were 
significant (p <0.05) up to day 70. Evaluation of efficacy as reported by the patient and observer was better for 
PNE and DDN groups. No adverse events were observed for either of the techniques.
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Introduction
Myofascial pain syndrome (MPS) is a complex disor-
der of the musculoskeletal system, with multifactorial 
involvement, which has several clinical presentations in 
multiple areas of the body. One of these is the orofacial 
region, affecting the masticatory muscles and the tem-
poromandibular joint (TMJ). MPS should be suspected 
in patients with pain and dysfunction of the masticatory 
muscles, together with the existence of trigger points 
(TrP) on palpation (1). TrPs are bands of muscle whose 
activation triggers tension and a deep and constant pain 
that can cause central excitation. The pain can be lo-
cal or referred, and is characterized by its tendency 
to become chronic, limiting interincisal opening and 
causing muscle weakness as valid diagnostic criteria 
to differentiate myofascial temporomandibular disease 
from properly intra-articular disorders (1-3). It has been 
observed that the masseter and temporal muscles along 
with the lateral pterygoid muscle (LPM) are the muscles 
most frequently involved in active TrP in patients with 
temporomandibular disorders of myofascial origin (4).
In the temporomandibular area, TrPs associated with 
MPS usually do not resolve without treatment (4). 
Management can include the control of parafunctional 
habits, use of a mouth guard, and analgesic-anti-inflam-
matory therapy. This can be in conjunction with inacti-
vation of TrPs by non-invasive methods, such as mas-
sages, ultrasound, muscle stretching with application of 
cold spray, and magnetic or electrical stimulation. Other 
mechanical treatments such as acupuncture or the direct 
application of medication to TrPs may be considered (5-
7). To date, several minimally invasive methods have 
been described (8,9), with deep dry needling (DDN) be-
ing one of the techniques used to inactivate TrPs (1). 
Several studies in the literature have reported on its 
safety, efficacy and low cost in the management of MPS 
with LPM involvement (4,10,11).
Percutaneous needle electrolysis (PNE) consists in the 
application of a low intensity galvanic current through 
an acupuncture needle to accelerate tissue regeneration 
(12). It has been used successfully in various muscu-
loskeletal pathologies, such as for the treatment of pa-
tellar tendinitis, tennis elbow, osteitis pubis and acute 
whiplash syndrome (13-16). However, to the best of our 
knowledge, no previous study has investigated the ef-
fect of PNE on TrPs of the masticatory muscles. The 
aim of the present study was to investigate if the PNE 
technique in LPM could reduce pain and improve man-
dibular mobility compared to DDN and a sham needling 
procedure (SNP). Secondary objectives were to assess 
the level of improvement in the general condition of the 
TMJ, as well as to assess the patient’s tolerance to the 
treatments performed and to side effects.
Material and Methods
-Subjects:
A randomized, double-blind, single-centre clinical trial 
was carried out in the outpatient clinic of the Depart-
ment of Oral and Maxillofacial Surgery of the Virgen 
del Rocío University Hospital, Seville (Spain), from 
June 2015 to June 2016.
The following diagnostic inclusion criteria were evalu-
ated: a) age between 18 and 65 years, b) myogenic pain 
in the temporo-mandibular area of at least 6 months’ 
duration, c) moderately limited mandibular movement 
(interincisal opening limited to <40 mm and requiring 
passive stretching to increase opening by > 5 mm), ac-
cording to Group I criteria of the RDC/TMD Consor-
tium (17), and d) criteria satisfied for active TrPs in the 
LMP (pain upon intraoral palpation, limited range of 
movement, painful chin protrusion against resistance, 
lateralization of the contralateral side with mouth open-
ing, and pain in the ipsilateral TMJ) according to the 
protocol used previously (1), following confirmation 
according to magnetic resonance study and panoramic 
radiography to rule out the presence of other conditions. 
Exclusion criteria were: a) the presence of TrPs in any 
other masticatory or cervical muscle, b) intra-articular 
pathology according to diagnostic criteria for temporo-
mandibular disorders (17), c) dentofacial deformities, d) 
facial paralysis, e) vascular diseases, f) tension head-
ache or migraine, g) previous infectious-inflammatory 
diseases of dental origin, h) belonephobia, i) fibromy-
algia, j) depression or k) other medical comorbidities 
(diabetes, hypo- or hyperthyroidism).
The study was approved by the Hospital Ethics Com-
mittee (approval number 2014PI/083). All patients pro-
vided their informed consent prior to inclusion.
-Study design:
Patients were randomly assigned by Epidat 4.0 software 
to one of the three groups. The principal investigator 
and patients were all blinded to the assigned group until 
completion of the statistical analysis. The clinical evalu-
ation of the patients was performed prior to treatment, 
Conclusions: PNE and DDN of the LPM showed greater pain reduction efficacy and improved MIO compared to 
SNP. Improvement was noted earlier in the PNE group than in the DDN group. 
Key words: Myofascial pain syndrome, myofascial trigger points, percutaneous needle electrolysis, deep dry nee-
dling, lateral pterygoid muscle.
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and on days 28, 42 and 70 after treatment. Data was 
collected at each visit by the same observer.
The PNE group received a transcutaneous puncture 
in the LPM, according to the technique described by 
Koole et al. (18). Sterile stainless-steel needles (length 
40 mm/ caliber 0.25 mm, with a cylindrical plastic 
guide, Agu-punt ®, Barcelona, Spain) were used for 
the muscle puncture. The puncture needles were con-
nected to an electrosurgical device, and the electrother-
apy equipment (EPI® Advanced Medicine, Barcelona, 
Spain) produced a continuous galvanic current of 2 mA 
for 3 seconds, three times through the cathode (electro-
surgical scalpel), while the patient held the anode (hand 
electrode).
The puncture technique used for the DDN group was 
performed as previously described (2,11). A deep intra-
muscular puncture of the TPs was carried out without 
the introduction of any substance (dry puncture) (19). 
The objective was to provoke a jump reaction or local 
twitch response when the needle was inserted in a TrP 
(8). During the procedure, the operator used the volume 
of the electrotherapy equipment as a guide, simulating 
the EPI® technique. For the SNP group, the needle was 
pressed against the skin with its plastic protective tube, 
simulating a puncture, with the same noise reproduced 
with the EPI® equipment.
In all cases, the preauricular area was cleaned with al-
cohol 90% prior to the procedure, and the unilateral up-
per and lower bellies of the LPM were located manually 
intra- and extraorally. The procedures were performed 
once per week, for 3 consecutive weeks. Two weeks af-
ter each procedure, all subjects were instructed to per-
form concentric exercises with the masticatory muscles. 
-Measures:
The main parameters evaluated were: a) pain at rest and 
with mastication according to a visual analogue scale 
(VAS), ranging from 0 (without pain) to 10 (worst pain 
imaginable), b) maximum interincisal opening (MIO) 
without causing pain or discomfort, using a jaw motion 
ruler to evaluate the distance between the upper and 
lower incisor in millimetres (Therabite® System ruler), 
and c) involvement of the TMJ, assessed by a 100-point 
questionnaire (0 worst case, 100 optimal) based on pain 
in daily activities (maximum 40 points), function (45 
points) and mastication (15 points). Secondary efficacy 
results were the overall efficacy scores evaluated by the 
patients and the observer using a 5-point scale, ranging 
from 0 worst-possible outcome to the optimum outcome 
of 4. Tolerability to the treatment was evaluated by the 
patient and the observer using a 5-point scale, ranging 
from 0-very bad to 4-excellent. The type and frequency 
of adverse events were recorded at each visit.
-Statistical analysis:
Data were analysed with SPSS statistical software (IBM 
Statistics 19.0). Pre- and post-intervention comparisons 
of the variables in each group were performed with 
the Friedman test, while variations within each group 
were analysed with the Wilcoxon signed-rank test (with 
Bonferroni correction). Comparisons between the study 
groups were made with the Kruskal-Wallis test for each 
time point. If differences were detected between groups, 
the Mann-Whitney U test was used to detect where the 
difference was. Values of p <0.05 were considered to 
indicate statistical significance. When the Bonferroni 
correction was applied, the statistical significance was 
p<0.016.
Results
Sixty patients were included in the study and randomly 
assigned to one of the three groups (20 patients in each 
group), from June 2015 to June 2016. The three groups 
had similar number of patients, and similar age distribu-
tions (median age of 39, range 18 to 62). Table 1 shows 
the demographic characteristics and pain descriptions 
for the 60 participants. No significant differences were 
found between the 3 groups. Two patients from the DDN 
group and one patient from the SNP group dropped out 












 PNE DDN SNP Significance 
(P) 
Age (y), median (range) 38.5 (18-57) 36 (19-58) 42 (25-62) 0.3247 
Gender Male/Female (n) 5 / 15 2 / 18 1 / 19 0.5273 































Table 1: Demographic characteristics and pain description of all participants.
VAS= visual analogue scale. Me= median. IQR= interquartile range. MIO= maximum interincisal opening. PNE= per-
cutaneous needle electrolysis. DDN= deep dry needling. SNP= sham needling procedure. TMJ= temporo-mandibular 
joint.
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the intention-to-treat analysis and the per-protocol anal-
ysis yielded identical results for all parameter measures; 
therefore, only the analysis per-protocol will be used to 
describe the results.
 
 Pain at rest: Intragroup analysis 
 Day 0 Day 28 Day 42 Day 70  Δ 0-28 Δ 28-42 Δ 42-70 
















0.001* <0,0001* 0.454 0.497 








0.001* 0.004* 0.008* 0.014* 








0.776    
 Pain at rest: Intergroup analysis  
 Day 0 Day 28 Day 42 Day 70 
Significance 
(P) (3) 
0.929 0.002* 0.001* <0.0001* 
PNE vs DDN Significance (P) 
(4) 
0.007* 0.012* 0.033 
PNE vs SNP Significance (P) (4) 0.002* 0.001* <0.0001* 
DDN vs SNP Significance (P) 
(4) 
0.308 0.023 0.010 * 
 
 Pain on mastication: Intragroup analysis 
 Day 0 Day 28 Day 42 Day 70  Δ 0-28 Δ 28-42 Δ 42-70 
 Me 
(IQR) 








PNE group 7 (6-8.3) 4 (2-5) 2.7 
(1-5.1) 
2 (1-4) <0.0001* 0.001* 0.077 0.351 
DDN group 8 (7-8) 5 (4.5-6) 3 (3-5.5) 3 (2-5) <0.0001*  <0.0001*  0.046 0.046 
SNP group 7 (5-8.5) 6 (4-9) 8 (4-9) 3 (3-8) 0.303    
 Pain on mastication: Intergroup analysis  
 Day 0 Day 28 Day 42 Day 70 
Significance 
(P) (3) 
0.670 0.016*  0.004*  0.004*  
PNE vs DDN Significance 
(P) (4) 
0.173 0.161 0.279 
PNE vs SNP  
Significance (P) (4) 
0.008*  0.005*  0.002* 
DDN vs SNP Significance 
(P) (4) 
0.073 0.011* 0.016* 
 
Table 2: Pain at rest and pain on mastication, as measured on a 10-cm VAS.
The reduction in pain at rest from day 0 to day 70 was 
statistically significant in the PNE and DDN groups (p 
<0.001) (Table 2). In the PNE group, this difference was 
first evident on day 28 (p<0.0001), while in the DDN 
Data from the tables are the median of the differences between the different days. VAS=visual analogue scale. Me=median. IQR=interquartile 
range. PNE=percutaneous needle electrolysis. DDN=deep dry needling. SNP=sham needling.
Significance (P)(1) = Friedman test for intragroup comparative analysis at each visit. * Results considered significant (p<0.05).
Significance (P)(2) = Wilcoxon test for the intragroup comparative analysis of VAS increase every two visits consecutive * Results considered 
significant (p<0.016).
Significance (P)(3) = Kruskal-Wallis test for intergroup comparative analysis at each visit. * Results considered significant (p<0.05).
Significance (P)(4) = Mann-Whitney U test for intergroup comparative analysis at each visit. * Results considered significant (p<0.016).
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group it was significant at all time points (p= 0.004, 
p= 0.008 and p= 0.014). When comparing among the 
three groups, differences were statistically significant at 
all time-points in the study (p<0.001). Differences be-
tween the PNE and SNP groups were found for all three 
days in which data was collected (p = 0.002, p = 0.001 
and p <0.001). Differences between the PNE and DDN 
groups were found between days 28 (p = 0.07) and 42 
(p = 0.12), and between DDN and SNP at day 70 (p = 
0.01). From day 0 to day 70, a significant reduction in 
pain with mastication was seen for the PNE and DDN 
groups (p <0.001) on day 28 (p = 0.001 and p <0.0001) 
(Table 2). When comparing between the three groups, 
significant differences were seen at all time-points of 
the study (p = 0.016, p = 0.004 and p = 0.004). Differ-
ences between the PNE and SNP groups were signifi-
cant at all time-points (p = 0.08, p = 0.05 and p = 0.02), 
while between the DDN and SNP groups differences 
were found on days 42 and 70 (p = 0.011 and p = 0.016).
MIO values improved significantly from day 0 to day 
70 in both the PNE and DDN groups (p <0.001) (Ta-
ble 3), with a significant reduction also seen for both 
groups on day 28 (p <0.0001 and p = 0.001). When 
comparing between the three groups, differences were 
obtained on all three days of the study in which data 
was collected (p <0.001, p = 0.002 and p = 0.001). For 
the PNE group, the increase in MIO was higher than 
in both the DDN group (p = 0.001, p = 0.007 and p = 
0.003) and the SNP group (p <0.001, p = 0.002 and p = 
0.001) at all times.
Values obtained in the 100-point questionnaire im-
proved significantly between day 0 and day 70 in the 
three groups (p <0.001) (Table 4). Significant differ-
ences were also found on day 28 for the PNE and DDN 
groups (p <0.0001 and p = 0.001). Again, when the three 
groups were compared, differences were significant on 
each of the three days in which data were recorded (p 
= 0.009, p = 0.004 and p <0.001). Values for the PNE 
group were higher than those for the SNP group on 
all three days (p = 0.006, 0 = 0.003 and p <0.001), and 
higher than the DDN group on day 70 (p = 0.001).
The only reported adverse effect was a self-limiting 
hematoma in one patient in the PNE group. No statisti-
cally significant differences in treatment tolerance were 
found between the three groups (Table 4). The evalua-
tion of the efficacy outcomes among the three groups 
was statistically significant both for the patient (p 
<0.0001) and the observer. When comparing between 
the three groups, this difference was greater for the 
PNE group than in the DDN and SNP groups, and in 
 
 Intragroup analysis 
 Day 0 Day 28 Day 42 Day 70  Δ 0-28 Δ 28-42 Δ 42-70 

















<0.0001* <0.0001*  0.291 0.360 








<0.0001* 0.001* 0.811 0.020 








       0.95    
 Intergroup analysis  
 Day 0 Day 28 Day 42 Day 70 
Significance 
(P) (3) 
0.765 <0.0001* 0.002* 0.001* 
PNE vs DDN Significance 
(P) (4)  
0.001* 0.007*  0.003* 
PNE vs SNP Significance (P) 
(4)  
<0.0001* 0.002* 0.001* 
DDN vs SNP Significance (P) 
(4) 
0.078 0.244 0.132 
 
Table 3: Maximal interincisal opening (MIO), as measured using a jaw motion ruler.
Data from the tables are the median of the differences between the different days. Me = median. IQR = interquartile range. PNE = percuta-
neous needle electrolysis. DDN = deep dry needling. SNP = sham needling procedure.
Significance (P) (1) = Friedman test for intragroup comparative analysis at each visit. * Results considered significant (p<0.05).
Significance (P) (2) = Wilcoxon test for the intragroup comparative analysis of VAS increase every two visits. * Results considered signifi-
cant (p<0.016).
Significance (P) (3) = Kruskal-Wallis test for intergroup comparative analysis at each visit. * Results considered significant (p<0.05).
Significance (P) (4) = Mann-Whitney U test for intergroup comparative analysis at each visit. * Results considered significant (p<0.016).
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A) Functionality of the TMJ, measured by the 100-point test: 
 Intragroup analysis 
 Day 0 Day 28 Day 42 Day 70  Δ 0-28 Δ 28-42 Δ 42-70 



















<0.0001* <0.0001* 0.529 0.028 








<0.0001* 0.001* 0.595 0.713 








<0.0001* 0.035 0.408 0.422 
 Intergroup analysis  
 Day 0 Day 28 Day 42 Day 70 
Significance 
(P) (3) 
0.312 0.009* 0.004* <0.0001* 
PNE vs DDN Significance 
(P) (4)  
0.064 0.022 0.001* 
PNE vs SNP Significance 
(P) (4)  
0.006* 0.003* <0.0001* 
DDN vs SNP Significance 
(P) (4)  
0.087 0.109 0.244 
Data from the tables are the median of the differences between the different days. 
Me = median. IQR = interquartile range. PNE = percutaneous needle electrolysis. DDN = deep dry needling. SNP = sham needling procedure. 
Significance (P) (1) = Friedman test for intragroup comparative analysis at each visit. * Results considered significant (p<0.05). 
Significance (P) (2) = Wilcoxon test for the intragroup comparative analysis of VAS increase every two visits. * Results considered significant 
(p<0.016). 
Significance (P) (3) = Kruskal-Wallis test for intergroup comparative analysis at each visit. * Results considered significant (p<0.05). 
Significance (P) (4) = Mann-Whitney U test for intergroup comparative analysis at each visit. * Results considered significant (p<0.016). 
 
B) Tolerance to treatment and subjective evaluation, measured by the 5-point test: 
 Tolerance to treatment at day 28 Subjective evaluation of improvement at 
day 70 
Me (IQR) Me (IQR) 
 Patient Observer  Patient Observer  
PNE group 4 (3-4) 4 (3-4) 4 (3-4) 4 (4-4) 
DDN group 4 (3-4) 4 (3-4) 3 (3-3) 3 (2,5-3) 
SNP group 4 (4-4) 4 (4-4) 2 (1-2) 2 (1-2) 
Significance 
(P) (1) 
0,238 0,390 <0,0001* <0,0001* 
PNE vs DDN 
Significance (P) (2)  
  0.02088* 0.041* 
PNE vs SNP Significance 
(P) (2)  
  <0.0001* <0.0001* 
DDN vs SNP 
Significance (P) (2)  
  0.00012* 0.0104* 
Data from the tables are the median of the differences. 
Me = median. IQR = interquartile range. PNE = percutaneous needle electrolysis. DDN = deep dry needling. SNP = sham needling procedure. 
Significance (P) (1) = Kruskal-Wallis test for intergroup comparative analysis. * Results considered significant (p<0.05). 
Significance (P) (2) = Mann-Whitney U test for intergroup comparative analysis. * Results considered significant (p<0.016). 
Table 4: Functionality of the TMJ, measured by the 100-point test, and tolerance to treatment and subjective evaluation, measured by the 
5-point test.
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turn greater in the DDN group than in the SNP group, in 
terms of both patient and observer perception.
Discussion
The objective of the present study was to evaluate the 
efficacy of PNE and DDN, two minimally-invasive 
techniques, applied three times to the LPM (once per 
week for three consecutive weeks). To do this, an analy-
sis was made of the pain intensity at rest and with mas-
tication, together with the measurements of the MIO 
ranges. The main findings can be outlined as follows: 
Compared to baseline values prior to treatment, PNE 
and DDN serve as effective treatments for MPS located 
in the LPM, improving pain, mandibular mobility and 
involvement of the TMJ (p <0.01). Both techniques 
immediate pain relief, and provided a stable outcome 
throughout the follow-up period as evidenced by signif-
icant improvements maintained until day 70 (p <0.05). 
It would seem that this effect was achieved earlier with 
PNE than with DDN. Pain reduction values were pro-
portionately higher compared to those of improvements 
in MIO. And finally, when comparing these results with 
the SNP group, significant differences were generally 
obtained on all of the study days in which evaluations 
were made.
The therapeutic management of MPS should be based 
on a multidisciplinary approach where TrP inactivation 
is the fundamental objective. While various puncture 
methods have been described in the literature that at-
tempt to inactivate myofascial TrPs (9,11), the principal 
difference between the different techniques consists of 
the injection, or not, of a substance into the TrP (dry 
puncture or wet puncture). No significant differences 
were reported in the literature between the use of DDN 
and the injection of any substance in the muscle belly 
(9).
DDN involves inactivation of TrPs via the insertion of 
an acupuncture needle without the administration of 
any substance. The mechanism of underlying the inac-
tivation is not known, but the technique has been shown 
to provide effective pain relief and short-term func-
tional recovery of muscles (20). The most accepted hy-
pothesis of the technique’s mechanism of action is that 
the needle damages the motor endplate, which in turn 
causes denervation of the distal axon, and interruption 
of the central pain circuit (21). To ensure the success 
of the procedure, the local twitch response that occurs 
when the needle enters the TrP seems to be the best 
indicator to establish the diagnosis (8), although occa-
sionally, identification of the local twitch response can 
be extremely difficult. The local twitch response corre-
sponds to a spinal reflex with a momentary contraction 
of the fibers that make up the taut band of muscle. The 
patient describes it as a cramp or tingling at the time of 
the puncture.
A limited number of studies have investigated the use 
of DDN to treat TrP in the orofacial area. Fernandez-
Carnero et al. (4) studied the use of DDN of the mas-
seter muscle. Gonzalez-Perez et al. (11) compared DDN 
with analgesic medication for MPS by treating TrPs in 
the LPM, with pain relief achieved almost immediately 
in the DDN group. Recently, Blasco-Bonora & Martín-
Pintado-Zugasti (3) used DDN on the temporal and 
masseter muscles. Taken together, these studies have 
reported statistically and clinically significant results in 
reducing both pain and dysfunction.
PNE is an emerging, minimally invasive physiothera-
peutic technique that involves the application of direct 
current (galvanic) through a puncture needle such that 
used in DDN, which acts as a negative electrode and 
induces an electrochemical reaction in the area to which 
it is applied. Cell necrosis is caused by this reaction, 
which results in a local inflammatory process in the 
soft tissue, inducing phagocytosis and repair of the af-
fected tissue (12). Tissue regeneration induced by PNE 
can restore function to the muscle, which is usually 
structurally damaged. PNE has been used to the present 
time to treat pathologies of the muscles and tendons, 
particularly in the lower limbs (13-16). To the best of 
our knowledge, no study has provided data on its use 
in orofacial pain as in our clinical trial. The paucity of 
other studies means that we are not available to compare 
our findings with others, making it difficult to arrive at 
definitive conclusions.
When comparing PNE with DDN in the present study, 
it was found that pain at rest and upon mastication de-
creased earlier in the PNE group. This was possibly be-
cause the technique combines both mechanical (needle) 
and electrical (galvanic current) stimulation (14). This 
effect could be explained by the inactivation of TrPs and 
by the acceleration of the regeneration of the damaged 
muscle with PNE. Three punctures were performed 
(one per week for three weeks) with application of a low 
intensity galvanic discharge in the LPM, with the aim 
of inactivating the TrPs. The slower improvement in the 
DDN group could have been due to the effect of the SNP 
and the blinding of the patients. In general, patients in 
the PNE group reported less post-puncture pain than 
in the DDN group. Improvements in MIO and in the 
100-point test score were similar in the PNE and DDN 
groups, generating an improvement in the perceived 
quality of life of patients owing to the larger variety of 
foods they could eat.
The diagnosis of the presence of a TrP in the LPM is 
difficult due to its deep location. Painful intraoral pal-
pation or limited mandibular opening are two common 
indirect clinical signs. The most reliable clinical test 
seems to be the painful protrusion against resistance 
(1,11,18,19). Exact localization of the TrP before the 
puncture can be achieved by palpation, ultrasound or 
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electromyography, although their use is complex and 
not validated (22-25). In general, the precise puncture 
of the LPM is a simple, reliable and validated technique 
(11,18) achieved via a transcutaneous approach, with the 
two muscle bellies easily reached (26).
Tolerance to the treatment was the same in the three 
groups. The overall evaluation by the patients and ob-
server of the effectiveness of the treatment, and the 
patients’ evaluation of treatment tolerance, were better 
for PNE and DDN than for SNP. Similarly, the over-
all efficacy evaluated both by patients and the observer 
was better for the PNE and DDN groups. No adverse 
reactions were detected with DDN, whereas in the 
PNE group a self-limiting hematoma was detected in 
one patient. As for any minimally invasive technique, 
both PNE and DDN were well tolerated without signifi-
cant contraindications or costs (16). The strengths of 
the present trial lie in the fact that it was randomized, 
blinded and controlled, comparing two active inter-
ventions. Furthermore, data collection at standardized 
time-points during the postoperative period facilitated 
comparisons with the pre-operative baseline status. 
This study has some limitations. Maintaining the blind-
ing of patients in a clinical trial based on an intervention 
involving a muscle puncture is challenging. This type 
of effect makes it extremely difficult to conduct studies 
with a SNP in which participants are truly blinded. In 
the SNP group of this study, a superficial puncture of the 
skin was performed with the plastic protection applied 
(sham dry needling). In this way, the influence of the 
placebo effect of the procedure and / or the natural evo-
lution of the TMD was controlled throughout the study. 
Tekin et al. (27) blinded participants by applying gentle 
pressure to the skin with the plastic protection; they de-
scribed a mild effect in the first days after treatment, 
which was attributed to the stimulation of superficial 
cutaneous receptors. To achieve a true placebo effect, 
Mayoral et al. (28) conducted a study in which patients 
were placed under general anesthesia, and therefore had 
no way of knowing afterwards what procedure they had 
been subjected to. Another of the limitations identified 
here was the infrequently identified, exclusive affecta-
tion of the LPM, since disorders of the LPM usually co-
exist with the involvement of other masticatory muscles 
such as the masseter or the temporal muscle (29). The 
evaluation was limited only to the effects observed in 
the short- and medium-term. To improve the validity of 
the study it would be important to increase the num-
ber of subjects, the time of follow-up, and the inclu-
sion of patients in whom other masticatory muscles are 
affected. In addition, it would be interesting to assess 
the treatment in patients with fibromyalgia or depres-
sion (30), which in this study were excluded. The use 
of EMG in the diagnostic work-up, and as a treatment 
support for puncture of the LPM, could also be studied.
Conclusions
In comparison with SNP, PNE and DDN of the LPM 
showed greater efficacy in relieving pain and improv-
ing MIO in patients with MPS in that muscle. The im-
provement was seen earlier in the PNE group than in the 
DDN group. No serious adverse events were observed 
with respect to any of the techniques used. Future stud-
ies should aim for greater validity by enrolling more pa-
tients and patients with other disorders of the temporo-
mandibular region, to determine the true role of PNE in 
the management of MPS in the orofacial area.
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